ESS
47
-4
CAH
47
15
CHD
58
10
TMO
51
4
CFG
54
-4
GLW
52
2
NAVI
27
-3
FLS
67
4
BAC
42
-2
HES
58
4
DE
40
-2
NKE
30
2
BBY
40
2
YUM
38
2
CRM
59
2
HRL
30
-6
SEE
49
3
AXP
63
3
MAC
62
-3
BA
53
5
ESS
47
-4
CAH
47
15
CHD
58
10
TMO
51
4
CFG
54
-4
GLW
52
2
NAVI
27
-3
FLS
67
4
BAC
42
-2
HES
58
4
DE
40
-2
NKE
30
2
BBY
40
2
YUM
38
2
CRM
59
2
HRL
30
-6
SEE
49
3
AXP
63
3
MAC
62
-3
BA
53
5
Financhill
Back

Can Fite Biofarma Vs. BioLine Rx Industry Stock Comparison

Sell
42

CANF
Can Fite Biofarma

Last Price:
2.19
Seasonality Move:
-3.85%
Sell
30

BLRX
BioLine Rx

Last Price:
0.43
Seasonality Move:
4.46%
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $2.16. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

  • The current BioLine Rx [BLRX] share price is $0.43. The Score for BLRX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $2.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

  • The BioLine Rx share price today is $0.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 39.76 Sell
Chaikin Money Flow: 5199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.03 - 2.65) Sell
Bollinger Bands (100): (2.11 - 3.17) Sell

BLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.22 Sell
Chaikin Money Flow: 564279 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.42 - 0.52) Sell
Bollinger Bands (100): (0.5 - 0.74) Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.38 Sell
20-day SMA: 2.43 Sell
50-day SMA: 2.29 Sell
200-day SMA: 2.4 Sell
8-day EMA: 2.34 Sell
20-day EMA: 2.38 Sell
50-day EMA: 2.4 Sell
200-day EMA: 2.52 Sell

BLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.42 Buy
20-day SMA: 0.45 Sell
50-day SMA: 0.56 Sell
200-day SMA: 0.78 Sell
8-day EMA: 0.43 Sell
20-day EMA: 0.46 Sell
50-day EMA: 0.54 Sell
200-day EMA: 0.79 Sell

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

BioLine Rx Earnings Growth & BLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioLine Rx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):